 |
 |
| |
| Wake Research Associates specializes in the following therapeutic areas: |
| Phase I, II, III and IV studies: |
| |
- Internal Medicine: 771 trials completed
- Gastroenterology: 558 trials completed
- Pulmonology/Immunology: 68 trials completed
- Provocative Meals: 21 trials completed
- Cardiology: 57 trials completed
- Infectious Disease: 45 trials completed
- Musculoskeletal disorders and Rheumatology: 45 trials completed
- Urology: 24 trials completed
- Psychiatry: 48 trials completed
- Neurology: 21 trials completed
- Medical Devices: 17 trials completed
- Gynecology & Women’s Health: 201 trials completed
- Pain Management: 45 trials completed
- Dermatology: 52 trials completed
- Sleep Medicine: 57 trials completed
- Healthy Volunteer Research: 60 trials completed
- Metabolic Disease and Obesity: 42 trials completed
- Smoking Cessation: 23 trials completed
- Vaccine Trials: 35 completed
|
| |
| |
|
| |
|
|
